SEER Seer, Inc. Stock Quote

SEER [NASD]

Index	-	P/E	-	EPS (ttm)	-	Insider Own	0.40%	Shs Outstand	60.84M	Perf Week	-10.60%
Market Cap	2.19B	Forward P/E	-	EPS next Y	-1.29	Insider Trans	-81.63%	Shs Float	44.45M	Perf Month	13.28%
Income	-	PEG	-	EPS next Q	-0.28	Inst Own	83.10%	Short Float	9.89%	Perf Quarter	8.94%
Sales	0.54M	P/S	4043.61	EPS this Y	-207.50%	Inst Trans	10.14%	Short Ratio	7.47	Perf Half Y	-29.65%
Book/sh	8.65	P/B	4.24	EPS next Y	-12.20%	ROA	-	Target Price	55.00	Perf Year	-
Cash/sh	8.68	P/C	4.22	EPS next 5Y	-	ROE	-	52W Range	26.48 - 86.55	Perf YTD	-34.66%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-7.80%	52W High	-57.76%	Beta	-
Dividend %	-	Quick Ratio	62.60	Sales past 5Y	-	Gross Margin	-	52W Low	38.07%	ATR	3.07
Employees	60	Current Ratio	62.90	Sales Q/Q	-65.00%	Oper. Margin	-	RSI (14)	47.64	Volatility	10.08% 7.99%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-373.20%	Profit Margin	-	Rel Volume	0.48	Prev Close	36.68
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Aug 12 AMC	Payout	-	Avg Volume	589.03K	Price	36.56
Recom	2.50	SMA20	-7.34%	SMA50	5.43%	SMA200	-20.64%	Volume	282,194	Change	-0.33%

Dec-29-20

Initiated

Morgan Stanley

Equal-Weight

$65

Dec-29-20

Initiated

JP Morgan

Overweight

$75

Dec-29-20

Initiated

Cowen

Outperform

Dec-29-20

Initiated

BofA Securities

Neutral

$69

Sep-02-21 04:05PM	Seer to Present at the Morgan Stanley Global Healthcare Conference GlobeNewswire +8.89%
Aug-31-21 10:06AM	Seer (NASDAQ:SEER) Is In A Good Position To Deliver On Growth Plans Simply Wall St.
Aug-13-21 12:00AM	Seer, Inc. (SEER) Q2 2021 Earnings Call Transcript Motley Fool +8.78%
Aug-12-21 04:06PM	Seer Reports Second Quarter 2021 Financial Results GlobeNewswire
04:01PM	Seer Bio Partners with Enlight Medical to Commercialize the Proteograph Product Suite in China GlobeNewswire
Jul-13-21 04:05PM	Seer to Report Second Quarter Financial Results on August 12, 2021 GlobeNewswire
May-10-21 04:05PM	Seer Reports First Quarter 2021 Financial Results GlobeNewswire -14.78%
May-04-21 04:05PM	Seer to Present at the BofA Securities 2021 Healthcare Conference GlobeNewswire -11.68%
Apr-12-21 04:05PM	Seer to Report First Quarter Financial Results on May 10, 2021 GlobeNewswire
Mar-30-21 05:30AM	Seer, Inc. (SEER) Q4 2020 Earnings Call Transcript Motley Fool +5.33%
Mar-29-21 04:05PM	Seer Reports Fourth Quarter and Full Year 2020 Financial Results and Fuels Commercial Progress in 2021 with New Collaborators and Partnerships GlobeNewswire
04:05PM	Seer and SCIEX Sign Commercial Agreement to Offer End-to-End Unbiased Proteomics Solutions GlobeNewswire
Mar-28-21 11:11PM	Alphabet, Baidu, NXP Semiconductors, Pinterest, Pure Storage What Cathie Wood's Ark Bought And Sold On Friday Benzinga
Mar-10-21 09:54AM	Tiger Cub Billionaire Lee Ainslies Top 10 Stock Picks Insider Monkey
Mar-04-21 03:25AM	Do Institutions Own Seer, Inc. (NASDAQ:SEER) Shares? Simply Wall St.
Mar-01-21 08:05AM	Seer to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021 GlobeNewswire +7.63%
Feb-24-21 04:05PM	Seer to Present at the Cowen 41st Annual Healthcare Conference GlobeNewswire +5.02%
Feb-17-21 08:00AM	Seer Appoints Deep Nishar and Mostafa Ronaghi, Ph.D. to its Board of Directors GlobeNewswire -6.81%
Feb-01-21 04:05PM	Seer Announces Closing of Public Offering of Common Stock GlobeNewswire
Jan-27-21 10:51PM	Seer Announces Pricing of Upsized Public Offering of Common Stock GlobeNewswire -7.15%
Jan-25-21 04:35PM	Seer Announces Proposed Public Offering of Common Stock GlobeNewswire
Jan-15-21 08:30PM	W.R. Grace, GameStop See Activist Action Barrons.com +5.89%
Jan-11-21 08:05AM	Seer Signs Commercial Agreement to Provide Complete End-to-End Solution for Unbiased, Deep, Rapid and Large-Scale Proteomics GlobeNewswire
08:00AM	Seer and Bruker Sign Commercial Agreement to Expand Market for Unbiased, Deep Proteomics GlobeNewswire
Jan-04-21 04:05PM	Seer to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-29-20 10:12AM	Benzinga's Top Upgrades, Downgrades For December 29, 2020 Benzinga -14.24%
08:36AM	This Was the Busiest Year for IPOs Since the Dot-Com Bubble. Expect Another Busy Year in 2021. Barrons.com
Dec-09-20 05:52AM	Israeli Healthtech Venture Fund Sees Industry Revolution Bloomberg +6.33%
Dec-08-20 05:40PM	Seer Announces Closing of Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire
Dec-04-20 04:30PM	Biotech IPOs Of Seer, Silverback Jump As Trading Gets Underway Investor's Business Daily
03:15PM	Seer Shares Soar 197% in Trading Debut Barrons.com

Seer, Inc., a life sciences company, engages in developing and commercializing products for researchers to unlock biological information. The company develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that provides workflow to make proteomic profiling, and the analysis of the samples needed to characterize the nature of the proteome. It intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. Seer, Inc. has a collaboration agreement with Discovery Life Sciences, LLC. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
OSTADAN OMEAD	President & COO	Sep 15	Sale	40.94	20,000	818,716	377,448	Sep 17 04:11 PM
Horn David R.	Chief Financial Officer	Sep 01	Option Exercise	2.70	10,000	27,000	240,966	Sep 02 05:29 PM
Horn David R.	Chief Financial Officer	Sep 01	Sale	39.58	10,000	395,751	230,966	Sep 02 05:29 PM
Horn David R.	Chief Financial Officer	Aug 02	Option Exercise	2.70	10,000	27,000	240,966	Aug 04 04:56 PM
Horn David R.	Chief Financial Officer	Aug 02	Sale	31.19	10,000	311,939	230,966	Aug 04 04:56 PM
Horn David R.	Chief Financial Officer	Jul 01	Option Exercise	2.70	10,000	27,000	240,966	Jul 06 04:14 PM
Horn David R.	Chief Financial Officer	Jul 01	Sale	31.32	10,000	313,238	230,966	Jul 06 04:14 PM
aMoon Growth Fund Limited Part	10% Owner	Jun 09	Sale	30.00	164,722	4,941,660	810,961	Jun 11 06:59 AM
aMoon Growth Fund Limited Part	10% Owner	Jun 09	Sale	30.00	835,278	25,058,340	4,112,235	Jun 11 06:59 AM
Horn David R.	Chief Financial Officer	Jun 02	Option Exercise	2.70	10,000	27,000	240,966	Jun 04 04:15 PM
Horn David R.	Chief Financial Officer	Jun 02	Sale	30.10	10,000	300,951	230,966	Jun 04 04:15 PM
Farokhzad Omid	CEO and Chair of the Board	Feb 17	Sale	64.15	354,741	22,756,635	0	Feb 19 07:45 PM
Invus Public Equities, L.P.	10% Owner	Feb 01	Sale	64.15	252,545	16,201,519	5,588,366	Feb 03 09:52 PM
Farokhzad Omid	CEO and Chair of the Board	Feb 01	Sale	64.15	775,910	49,774,627	0	Feb 03 09:52 PM
Farokhzad Omid	CEO and Chair of the Board	Feb 01	Sale	64.15	313,369	20,102,621	297,487	Feb 03 09:52 PM
Farokhzad Omid	CEO and Chair of the Board	Jan 27	Option Exercise	0.04	309,313	13,239	588,536	Jan 29 06:21 PM
aMoon 2 Fund Limited Partnersh	10% Owner	Dec 09	Buy	19.00	63,024	1,197,456	975,683	Dec 10 04:15 PM
aMoon 2 Fund Limited Partnersh	10% Owner	Dec 09	Buy	19.00	726,449	13,802,531	4,947,513	Dec 10 04:15 PM
MCGUIRE TERRANCE	Director	Dec 08	Buy	19.00	78,947	1,499,993	78,947	Dec 09 08:23 PM
Invus Public Equities, L.P.	10% Owner	Dec 08	Buy	19.00	790,000	15,010,000	5,840,911	Dec 10 04:15 PM
aMoon 2 Fund Limited Partnersh	10% Owner	Dec 08	Buy	19.00	100,000	1,900,000	4,221,064	Dec 10 04:15 PM
Farokhzad Omid	CEO and Chair of the Board	Dec 08	Sale	19.00	526,315	9,999,985	252,915	Dec 10 08:44 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience